Bahl & Gaynor Inc Novartis Ag Transaction History

Bahl & Gaynor Inc

  • $19.6 Billion
  • Q1 2025

A detailed history of Bahl & Gaynor Inc transactions in Novartis Ag stock. As of the latest transaction made, Bahl & Gaynor Inc holds 93,554 shares of NVS stock, worth $10.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
93,554
Previous 99,001 5.5%
Holding current value
$10.8 Million
Previous $9.63 Million 8.26%
% of portfolio
0.05%
Previous 0.05%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$97.14 - $115.57 $529,121 - $629,509
-5,447 Reduced 5.5%
93,554 $10.4 Million
Q4 2024

Feb 06, 2025
BUY
$96.78 - $117.18 $41,518 - $50,270
429 Added 0.44%
99,001 $9.63 Million
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $384,508 - $437,984
-3,623 Reduced 3.55%
98,572 $11.3 Million
Q2 2024

Aug 07, 2024
SELL
$92.57 - $107.37 $75,444 - $87,506
-815 Reduced 0.79%
102,195 $10.9 Million
Q1 2024

May 10, 2024
SELL
$95.27 - $108.47 $76,978 - $87,643
-808 Reduced 0.78%
103,010 $9.96 Million
Q4 2023

Feb 02, 2024
SELL
$92.27 - $101.54 $25,005 - $27,517
-271 Reduced 0.26%
103,818 $10.5 Million
Q3 2023

Nov 03, 2023
SELL
$94.73 - $105.13 $210,205 - $233,283
-2,219 Reduced 2.09%
104,089 $10.6 Million
Q2 2023

Aug 14, 2023
BUY
$92.52 - $104.91 $277 - $314
3 Added 0.0%
106,308 $10.7 Million
Q1 2023

May 03, 2023
SELL
$80.03 - $92.81 $95,715 - $111,000
-1,196 Reduced 1.11%
106,305 $9.78 Million
Q4 2022

Feb 10, 2023
BUY
$75.55 - $92.52 $52,733 - $64,578
698 Added 0.65%
107,501 $9.75 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $567,782 - $664,048
-7,610 Reduced 6.65%
106,803 $8.12 Million
Q2 2022

Aug 08, 2022
SELL
$80.52 - $93.75 $601,484 - $700,312
-7,470 Reduced 6.13%
114,413 $9.67 Million
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $808,950 - $915,080
-10,098 Reduced 7.65%
121,883 $10.7 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $605,959 - $670,052
-7,603 Reduced 5.45%
131,981 $11.5 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $130,193 - $151,462
-1,592 Reduced 1.13%
139,584 $11.4 Million
Q2 2021

Aug 06, 2021
SELL
$85.24 - $94.15 $1.64 Million - $1.81 Million
-19,234 Reduced 11.99%
141,176 $12.9 Million
Q1 2021

May 11, 2021
SELL
$83.5 - $98.47 $197,060 - $232,389
-2,360 Reduced 1.45%
160,410 $13.7 Million
Q4 2020

Feb 02, 2021
SELL
$78.07 - $94.43 $172,846 - $209,068
-2,214 Reduced 1.34%
162,770 $15.4 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $425,238 - $471,107
-5,177 Reduced 3.04%
164,984 $14.3 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $353,906 - $398,380
-4,373 Reduced 2.51%
170,161 $14.9 Million
Q1 2020

May 26, 2020
BUY
$70.67 - $99.01 $12.3 Million - $17.3 Million
174,534 New
174,534 $14.4 Million
Q1 2020

May 15, 2020
SELL
$70.67 - $99.01 $13.4 Million - $18.7 Million
-189,238 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $386,154 - $436,603
-4,578 Reduced 2.36%
189,238 $17.9 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $8,040 - $8,860
-94 Reduced 0.05%
193,816 $16.8 Million
Q2 2019

Aug 12, 2019
SELL
$75.4 - $92.8 $863,782 - $1.06 Million
-11,456 Reduced 5.58%
193,910 $17.7 Million
Q1 2019

May 13, 2019
SELL
$75.32 - $86.15 $263,620 - $301,525
-3,500 Reduced 1.68%
205,366 $19.7 Million
Q4 2018

Feb 12, 2019
SELL
$73.66 - $82.02 $438,129 - $487,854
-5,948 Reduced 2.77%
208,866 $17.9 Million
Q3 2018

Nov 09, 2018
SELL
$66.94 - $77.43 $372,788 - $431,207
-5,569 Reduced 2.53%
214,814 $18.5 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $17.3 Million - $19.6 Million
-266,800 Closed
0 $0
Q1 2018

May 11, 2018
SELL
$70.39 - $84.15 $448,806 - $536,540
-6,376 Reduced 2.33%
266,800 $21.6 Million
Q4 2017

Feb 13, 2018
BUY
$72.33 - $77.64 $14,393 - $15,450
199 Added 0.07%
273,176 $22.9 Million
Q3 2017

Nov 13, 2017
SELL
$74.14 - $77.27 $1.07 Million - $1.12 Million
-14,438 Reduced 5.02%
272,977 $23.4 Million
Q2 2017

Aug 11, 2017
SELL
N/A
-127,018 Reduced 30.65%
287,415 $24 Million
Q2 2017

Aug 10, 2017
BUY
N/A
414,433
414,433 $30.2 Million

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email